because oncology is unique
What we do
ONKOS Consulting is an oncology-focused consultancy whose mission is to deliver cutting-edge insight and analysis in a competitive and complex environment. We believe that oncology is unique and that a complete set of scientific, clinical and commercial expertise is required to fully harness the complexities of the oncology space including population segmentation, biomarker diversity, treatment algorithms, patient flows and treatment regimens.
ONKOS Consulting recognizes that oncology is at the forefront of modern healthcare challenges. The costly development of better targeted medicines for smaller patient populations at a time of growing economic pressures on healthcare systems is a prominent theme in oncology. These are your challenges. It is our mission to help you make informed decisions.
Whether they are KOLs, pharma stakeholders or scientists, we speak their language to gather powerful insights and drive informed conclusions.
ONKOS Consulting can help you build patient flow forecasts that capture the complexity of oncology market dynamics in a transparent and actionable format.
ONKOS Consulting develops forward-looking epidemiology studies that anticipate the impact of the most recent developments (biomarkers, disruptive therapies etc.) on the prevalence of cancers.
Thanks to our oncology expertise and primary research capabilities, we deliver state-of-the-art competitive intelligence to allow you to maintain a competitive edge.
Oncology conferences are key opportunities to monitor your competitors' activity, their commercial messaging and the most recent developments and results.
No one solution fits all. ONKOS Consulting will work with you to develop a customized project that will suit your needs. Feel free to contact us to openly discuss the feasibility of your projects.
Who we are
We are a network of professionals passionate about oncology. With years of experience delivering customized oncology projects and covering dedicated conferences, we want to share our passion to best serve our clients. Our network is dynamic and stretches across the globe to cover all oncology markets.
Let's discuss blood cancers at EHA2017
The unique opportunity to review most recent advances in blood cancers
Meet the team at ASCO2017
Contact us to meet the team and discuss deep oncology topics
Lung cancer networking at ELCC2017
The best opportunty to network with European lung cancer experts
What's hot in early clinical at TAT2017
We will be discussing new molecular targets and innovative cancer therapeutics in the early phases of clinical development